[{"address1": "100 Palmetto Park Place", "city": "Ponte Vedra", "state": "FL", "zip": "32081", "country": "United States", "phone": "904 373 5940", "fax": "904 834 7169", "website": "https://www.treace.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.", "fullTimeEmployees": 516, "auditRisk": 5, "boardRisk": 9, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 5.86, "open": 5.87, "dayLow": 5.77, "dayHigh": 6.0, "regularMarketPreviousClose": 5.86, "regularMarketOpen": 5.87, "regularMarketDayLow": 5.77, "regularMarketDayHigh": 6.0, "beta": 0.183, "forwardPE": -6.988235, "volume": 1405396, "regularMarketVolume": 1405396, "averageVolume": 1256024, "averageVolume10days": 1249160, "averageDailyVolume10Day": 1249160, "bid": 5.92, "ask": 5.98, "bidSize": 100, "askSize": 100, "marketCap": 368328128, "fiftyTwoWeekLow": 3.92, "fiftyTwoWeekHigh": 25.76, "priceToSalesTrailing12Months": 1.878928, "fiftyDayAverage": 7.5992, "twoHundredDayAverage": 10.889, "currency": "USD", "enterpriseValue": 328318880, "profitMargins": -0.27929002, "floatShares": 43245679, "sharesOutstanding": 62008100, "sharesShort": 4549566, "sharesShortPriorMonth": 2758573, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0734, "heldPercentInsiders": 0.27825, "heldPercentInstitutions": 0.68467003, "shortRatio": 2.54, "shortPercentOfFloat": 0.094, "impliedSharesOutstanding": 62008100, "bookValue": 2.041, "priceToBook": 2.9103382, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -54749000, "trailingEps": -0.88, "forwardEps": -0.85, "enterpriseToRevenue": 1.675, "enterpriseToEbitda": -6.496, "52WeekChange": -0.75970876, "SandP52WeekChange": 0.26238096, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TMCI", "underlyingSymbol": "TMCI", "shortName": "Treace Medical Concepts, Inc.", "longName": "Treace Medical Concepts, Inc.", "firstTradeDateEpochUtc": 1619184600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d2ef1b92-1f58-34f4-bbe0-93045fa4b67f", "messageBoardId": "finmb_282593338", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.94, "targetHighPrice": 8.0, "targetLowPrice": 5.5, "targetMeanPrice": 6.6, "targetMedianPrice": 6.5, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 110006000, "totalCashPerShare": 1.775, "ebitda": -50542000, "totalDebt": 70113000, "quickRatio": 2.999, "currentRatio": 3.983, "totalRevenue": 196031008, "debtToEquity": 55.473, "revenuePerShare": 3.181, "returnOnAssets": -0.14333001, "returnOnEquity": -0.38555, "freeCashflow": -25388876, "operatingCashflow": -24537000, "revenueGrowth": 0.211, "grossMargins": 0.80988, "ebitdaMargins": -0.25783002, "operatingMargins": -0.3701, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]